LabCorp announced that it is launching a new return-to-work service for employers, according to a company news release.
LabCorp said it launched the service to respond to requests from companies developing return-to-work strategies for the summer and fall.
LabCorp Employer Services provides customized return-to-work solutions using LabCorp’s trained medical staff for employee check-in health questionnaires, temperature screens, and COVID-19 test collection at the employer site or offsite. The service gives employers access to LabCorp’s COVID-19 testing solutions including its at-home collection test kit, its fingerstick antibody blood test, and in the fall, flu vaccination services.
LabCorp’s fingerstick, or dried blood spot, IgG antibody test is being provided as a laboratory developed test and uses the EUROIMMUN test, which received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA). LabCorp completed independent validation studies.
Visit LabCorp for more news
